Enterprise Value
-34.27M
Cash
114.2M
Avg Qtr Burn
-14.82M
Short % of Float
5.95%
Insider Ownership
25.37%
Institutional Own.
70.52%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
Epetraborole Details Lung disease, Mycobacterium avium complex lung disease | Phase 2/3 Data readout |